4RARETier 5
기사 목록Ultragenyx Pharmaceutical Inc. 4
0001193125-26-332547
View on SEC EDGAREVP and Chief Legal Officer Karah Herdman Parschauer sold 1,900 shares of Ultragenyx Pharmaceutical Inc. common stock at $24.92 per share.
On August 3, 2026, Karah Herdman Parschauer, EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc., sold 1,900 shares of Ultragenyx common stock at an average price of $24.92 per share for total proceeds of approximately $47,348, leaving her with direct ownership of 92,562 shares, which includes previously reported shares underlying restricted stock units subject to vesting conditions.
Filing Facts
- CIK
- 1515673
- Ticker
- RARE
- Form
- 4
- Source Type
- fda
- Accession
- 0001193125-26-332547
- Alert Tier
- 5